- Open Access
Horizontal transfer of exosomal microRNAs transduce apoptotic signals between pancreatic beta-cells
© Guay et al.; licensee BioMed Central. 2015
- Received: 31 October 2014
- Accepted: 6 March 2015
- Published: 19 March 2015
Diabetes mellitus is a common metabolic disorder characterized by dysfunction of insulin-secreting pancreatic beta-cells. MicroRNAs are important regulators of beta-cell activities. These non-coding RNAs have recently been discovered to exert their effects not only inside the cell producing them but, upon exosome-mediated transfer, also in other recipient cells. This novel communication mode remains unexplored in pancreatic beta-cells. In the present study, the microRNA content of exosomes released by beta-cells in physiological and physiopathological conditions was analyzed and the biological impact of their transfer to recipient cells investigated.
Exosomes were isolated from the culture media of MIN6B1 and INS-1 derived 832/13 beta-cell lines and from mice, rat or human islets. Global profiling revealed that the microRNAs released in MIN6B1 exosomes do not simply reflect the content of the cells of origin. Indeed, while a subset of microRNAs was preferentially released in exosomes others were selectively retained in the cells. Moreover, exposure of MIN6B1 cells to inflammatory cytokines changed the release of several microRNAs. The dynamics of microRNA secretion and their potential transfer to recipient cells were next investigated. As a proof-of-concept, we demonstrate that if cel-miR-238, a C. Elegans microRNA not present in mammalian cells, is expressed in MIN6B1 cells a fraction of it is released in exosomes and is transferred to recipient beta-cells. Furthermore, incubation of untreated MIN6B1 or mice islet cells in the presence of microRNA-containing exosomes isolated from the culture media of cytokine-treated MIN6B1 cells triggers apoptosis of recipient cells. In contrast, exosomes originating from cells not exposed to cytokines have no impact on cell survival. Apoptosis induced by exosomes produced by cytokine-treated cells was prevented by down-regulation of the microRNA-mediating silencing protein Ago2 in recipient cells, suggesting that the effect is mediated by the non-coding RNAs.
Taken together, our results suggest that beta-cells secrete microRNAs that can be transferred to neighboring beta-cells. Exposure of donor cells to pathophysiological conditions commonly associated with diabetes modifies the release of microRNAs and affects survival of recipient beta-cells. Our results support the concept that exosomal microRNAs transfer constitutes a novel cell-to-cell communication mechanism regulating the activity of pancreatic beta-cells.
- Pancreatic beta-cells
- Cell-to-cell communication
Pancreatic beta-cells, located within the islets of Langerhans, play a central role in the regulation of blood glucose homeostasis by secreting insulin in response to the organism demand. Insufficient insulin supply, resulting from beta-cell dysfunction and/or death, leads to chronic hyperglycemia and favor the development of diabetes mellitus, the most common metabolic disorder worldwide. Proper functioning of insulin-secreting cells is governed by a complex array of signals of metabolic, hormonal and neuronal origin that ensure a tight control of insulin release. MicroRNAs (miRNAs), a class of non-coding RNAs, have been identified as important determinants of the functional integrity of pancreatic beta-cells. These small RNA molecules regulate not only the differentiation of beta-cells but also various aspects of the activity of mature beta-cells including proliferation, survival, insulin biosynthesis and secretion [1-4]. miRNAs act by binding to the 3’UTR of target mRNAs of specific genes leading to translational repression and/or to a decrease in messenger stability . Beside their activity accomplished inside the cell producing them, these small RNA molecules can also be released in the extracellular environment packaged within microvesicles or in association with proteins or high-density lipoproteins (HDL) [6-8]. The role of circulating miRNAs remains to be ascertained but, since miRNAs transported by HDL or exosomes can be transferred in active form to other cells, they have been suggested to represent a novel cell-to-cell communication mode [8,9].
Exosomes are microvesicles of 50–150 nm of diameter that originate from the late endosomal pathway and are secreted in the extracellular space upon fusion of multivesicular bodies with the plasma membrane . The biogenesis and release of exosomes have been shown to involve different mechanisms including the ceramide pathway, the ESCRT system and the exocytotic machinery [11-13]. Exosomes accumulate in the culture media of several cell types, and are present in different body fluids such as blood, urine or saliva . These extracellular vesicles carry proteins and nucleic acids, including miRNAs that can be transferred to recipient cells [9,15]. Little is known about the sorting of proteins and RNAs into exosomes, but horizontal transfer of the exosomal cargo to neighboring cells has been suggested to allow rapid phenotype adjustment in response to changes in physiological or physiopathological conditions . RISC (RNA Induced Silencing Complex) components, which are essential for miRNA action, are also present in exosomes . Several cell types have been shown to release miRNAs that can be transferred in active form to recipient cells, where they can exert their regulatory activity on target genes [9,17,18]. Exosomal miRNAs were reported to be involved in a broad range of biological processes including the immune reaction and in the regulation of the cardiovascular system [19,20].
Pancreatic islets and different beta-cell lines have been reported to release exosome-like microvesicles [21-25]. The function of beta-cell exosomes is just beginning to unfold, but there is already evidence indicating that these extracellular vesicles may participate in the cross-talk with endothelial cells or lymphocytes [21,24]. The possible contribution of exosomal miRNAs in the autocrine signaling between pancreatic beta-cells has, however, so far not been explored.
In the present study, we investigated if the release of exosomes from pancreatic beta-cells can affect the surrounding cells and can constitute a cell-to-cell communication mode permitting a concerted adaptation of beta-cells to environmental cues. Our data indicate that certain miRNAs are preferentially secreted in exosomes while others are specifically retained inside beta-cells. Moreover, we found that the miRNA content of exosomes is modified upon exposure of the beta-cells to inflammatory mediators. Interestingly, incubation with exosomes originating from cells treated with cytokines induced apoptosis of naïve beta-cells, an effect that was prevented by inhibition of Ago2, a component of the RISC complex that is essential for miRNA action, in recipient beta-cells. Taken together, these results suggest that exosome-mediated transfer of miRNAs constitute a novel communication mode between pancreatic beta-cells.
Isolation and characterization of exosomes released by pancreatic beta-cells
Effect of physiopathological conditions on the pool of miRNAs released by pancreatic beta-cells
We also examined if exposure to physiopathological conditions known to favor the development of diabetes mellitus affect the pool of miRNAs released by beta-cells (Additional file 2: Table S1). Interestingly, treatment of MIN6B1 cells with a mix of pro-inflammatory cytokines, including IL-1β, TNFα and IFNγ, changed the level of 67 of the 204 miRNAs detected in exosomes (p < 0.05; Fold change > 1.5). Indeed, the level of 28 miRNAs diminished in exosomes of MIN6B1 cells treated with cytokines whereas 39 of them were present at higher levels (Figure 3C). For example, miR-546 and miR-710 were increased in response to cytokines whereas let-7e and miR-212-3p were more abundant in exosomes of untreated MIN6B1 cells (see Additional file 3: Figure S2B for confirmation of these results by qPCR). Interestingly, among the miRNAs found to be upregulated in exosomes in response to cytokines, several of them including miR-146a, miR-146b, miR-195, miR-290a-3p, miR-362-3p and miR-497 are known to be involved in cell death [29-34].
Exosomes released during cytokine exposure affect survival of receiving beta-cells
Exosome-induced apoptosis in recipient beta-cells is mediated by miRNA transfer
Coordinated activity of pancreatic beta-cells located within the islets of Langerhans is essential to insure a tight control of blood glucose levels and to prevent the deleterious effects of hypo- or hyperglycemia. This coordination is achieved both by direct cell-to-cell contact, mediated by cell adhesion molecules or gap junctions, and through the release of a variety of signaling molecules with paracrine or autocrine functions [35,36]. In the present study, we investigated the biological relevance of a novel signaling mechanism involving the horizontal transfer of miRNAs between pancreatic beta-cells. We found that miRNAs carried by exosomes do not simply reflect the cellular content in physiological or physiopathological conditions. Our results rather suggest that particular miRNAs are preferentially released in exosomes while others are selectively retained by the cells. In agreement with our observation, some miRNAs including miR-126, miR-139, miR-223 and miR-483 were found to be enriched by more than 10 fold compared to the cellular content in exosomes originating from human islets . Selective accumulation of specific miRNAs in exosomes released by other cell types was also reported [7,9,15,37,38]. The mechanisms governing the loading of miRNAs in exosomes remain unknown, but recent publications tried to unravel them. Villarroya-Beltri et al.  reported enrichment in exosomes of T lymphocytes of miRNAs containing the GGAG sequence that binds to the ribonucleoprotein hnRNPA2B1. They found that sumoylation regulates the binding of hnRNPA2B1 to miRNAs and favors the trafficking of the non-coding RNAs toward the exosomes. Squadrito et al. noted an inverse correlation in macrophages between the level of the miRNAs sorted in exosomes and the abundance of their target transcripts in the cells . This finding suggests that changes in the level of the mRNAs targeted by a given miRNA can influence its re-localization from cytoplasm/P-bodies to multivesicular bodies and hence its release in the extracellular space. More studies are needed to confirm these findings in different cell types and to investigate whether the motifs and/or pathways directing the intracellular trafficking of miRNAs are universally conserved or are specific for each cell type.
We observed that incubation of MIN6B1 cells in the presence of pro-inflammatory cytokines, a condition typically encountered in pre-diabetic and diabetic states, modifies the profile of the miRNAs carried by exosomes. Incubation of naïve beta-cells with exosomes from donor cells treated with cytokines does not affect the secretory functions of the recipient cells but results in an increase in apoptosis. During the preparation of this manuscript, Zhu and colleagues published a study demonstrating that incubation of INS1 cells, another beta-cell line, in the presence of low doses of cytokines release exosomes capable of protecting the recipient cells from cytokine-induced cell death . These authors did not test the functional impact of exosomes produced from INS1 cells treated with higher doses of cytokines and they have not investigated the potential role of miRNAs in the protective activity of these extracellular vesicles. The effect of pro-inflammatory cytokines on beta-cells is known to be concentration dependent. Low doses of cytokines favor the activity and survival of the cells whereas at higher concentrations they promote cell death [41,42]. It is possible that this dual effect of cytokines would be reflected in the release of different types of exosomes exerting either protective or deleterious impacts on the survival of the receiving cells according to the concentration of cytokines experienced by the donor cells. Should this hypothesis be confirmed, exosomes would represent a novel cell-to-cell communication mode permitting a concerted response to inflammatory mediators. The regulation of proliferation by paracrine signals has been less studied, but there is indication suggesting that extracellular vesicles may be implicated also in this phenomenon. Indeed, in a model of HNF1a deficiency, Bonner et al. observed that apoptotic INS1 cells release microparticles that stimulate proliferation of naïve recipient INS1 cells . This proliferative signal was prevented by filtration of the conditioned media, suggesting that it is mediated by microparticles of relatively large sizes (>0.22 μm) rather than by exosomes or soluble factors. It is not yet known whether or not this proliferative effect is linked to the transfer of miRNAs or of other regulatory molecules transported by the microparticles.
The precise cascade of events elicited by exosomes and culminating in beta-cell apoptosis remains to be elucidated. Our data suggest that miRNAs may play a role in the effect of exosomes on beta-cell survival. Indeed, we demonstrated that the incubation of donor cells with cytokines alters the pool of released miRNAs and that exosomal miRNAs can be delivered to recipient beta-cells. Moreover, silencing of Ago2, a component of the RISC complex that is essential for miRNA action, in recipient cells prevents the apoptotic effect of exosomes originating from cells exposed to cytokines. Ago2 is known to be present also in exosomes . However, our data indicate that the transferred miRNAs rely mainly on the RISC complex of the recipient cells to induce cell death. Taken together, our observations suggest that the apoptotic signal may by transduced by the miRNAs carried within the exosomes. However, we cannot exclude that other components of the exosomes elicit secondary changes in miRNA expression in recipient beta-cells contributing to the deleterious impact on cell survival.
This study highlighted a novel category of signals generated by pancreatic beta-cells exposed to pro-inflammatory mediators. The exosomes released by beta-cells under these conditions will not only permit to achieve a coordinated response to inflammation of neighboring beta-cells but may also alert the immune system and favor the activation of an autoimmune reaction culminating in the development of type 1 diabetes . Thus, the identification of the molecular mechanisms underlying this novel cell-to-cell communication mode and, in particular, a precise definition of the role played by miRNAs in this process will possibly help the design of new strategies to prevent or treat diabetes.
Pancreatic beta-cell lines
The murine insulin-secreting cell line MIN6B1  (passage 15–32) was cultured in DMEM- GlutaMAXTM medium (Gibco) containing 25 mM of glucose and 4 mM of L-glutamine and supplemented with 15% FCS, 50 U/ml penicillin, 50 μg/ml streptomycin, and 70 μmol/L ß-mercaptoethanol (referred to as full DMEM media in the text). For exosome characterization and analysis by microarray and qPCR, FCS was pre-centrifuged at 100’000 x g for 2 h to remove bovine exosomes. Rat insulinoma INS-1 derived 832/13 cells  (passages 50–62) were cultured in RPMI 1640- GlutaMAXTM medium (Gibco) containing 11.1 mM glucose and 2 mM L-glutamine and supplemented with 10% fetal calf serum (Amimed), 10 mM HEPES, 1 mM sodium pyruvate and 50 μM β-mercaptoethanol (referred to as complete RPMI media in the text). For exosome isolation, MIN6B1 cells were seeded at 4 x 106 cells and cultured for 48 h in full DMEM media. To evaluate the effect of pro-inflammatory cytokines, the medium included 30 ng/ml IFNγ (R&D systems), 10 ng/ml TNFα (R&D systems) and 1 ng/ml IL-1β (Sigma-Aldrich) from the beginning of the culture period or during the last 24 h of incubation. Both cell lines were cultured at 37°C in a humidified atmosphere (5% CO2, 95% air).
Human islets were obtained from the Cell Isolation and Transplantation Center of the University of Geneva, though the ECIT “Islets for Research” distribution program sponsored by the Juvenile Diabetes Research Foundation. The use of human islets for research was approved by the local institutional ethical committee. For exosome isolation, human islets were cultured in CMRL medium (Gibco) supplemented with 10% FCS, 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM glutamine, and 250 μM HEPES for up to 48 h.
Male Wistar rats (250 g) and male C57Bl/6 N mice (11–13 weeks-old) were obtained from Charles River Laboratories (L’arbresle, France). All animal procedures were performed in accordance with the NIH guidelines and protocols were approved by the Swiss Research Councils and Veterinary Offices. Rodent islets were isolated by collagenase digestion of the pancreas  followed by Histopaque density gradient and hand-picking to separate pancreatic islets from digested exocrine tissue. Isolated islets were incubated overnight in complete RPMI 1640- GlutaMAXTM medium without β-mercaptoethanol and supplemented with 100 μg/mL streptomycin and 100 IU/mL penicillin, at 37°C in a humidified atmosphere (5% CO2, 95% air). After overnight recovery, media were collected for exosome isolation and islets were dissociated by incubation for 3 min at 37°C in Ca2+/Mg2+ free PBS containing 3 mM EGTA and 0.002% trypsin, with gentle shaking by pipetting.
Exosomes were isolated by ultra-centrifugation as described previously . Briefly, culture media of MIN6B1 or INS 832/13 cells or from mouse, rat or human islets were collected and centrifuged first at 300 g for 5 min to pellet the intact cells and then at 2’000 g for 10 min to discard the dead cells. Supernatants were then centrifuged at 10’000 g for 30 min to remove cell debris. Exosomes were isolated from the final supernatant by ultra-centrifugation at 100’000 g for 2 h. The pellet containing the exosomes was washed with PBS and re-centrifuged at 100’000 g for 2 h. Exosomes were collected in a minimal volume of PBS and stored at -80°C. Exosomes isolated from MIN6B1 treated with cytokines were diluted in PBS to a final volume corresponding to 1:100 of the original culture volume. Protein concentration was determined by Bradford assay (BioRad). MIN6B1 recipient cells were incubated for 72 h with exosome preparations at a final concentration of 50 μg/ml . To evaluate the impact of small amounts of soluble molecules potentially carried over during the isolation procedure, recipient cells were incubated with the same volume of supernatant but depleted from exosomes. Survival and functional assays were then performed as described below.
Exosome size distribution was determined by Nanoparticle Tracking Analysis using the NanoSight system (NanoSight, UK). This technique measures the Brownian motion of particles for which the speed of movement, or diffusion coefficient, is related to particle size through the Stokes-Einstein. Filtered PBS was used as solvent to dilute exosomes.
Proteins from exosome samples or cell lysates were migrated on 10% SDS-PAGE gels. Following electrophoresis, the proteins were transferred to PVDF membranes that were blocked at room temperature in Tris-buffered saline/0.3% Tween-20 containing 4% of BSA. Membranes were then incubated overnight at 4°C with gentle shaking with antibodies against CD81 (sc-166028), Alix (sc-49268) or TSG101 (sc-6037), purchased from Santa Cruz Biotechnology, or against Calnexin (S0998) obtained from Epitomics. All antibodies were diluted 1/1000 in 1% BSA. The signal was detected using a horseradish peroxidase-conjugated secondary antibody (BioRad) and was revealed with the enhanced chemiluminescence system from Pierce.
RNA extraction from beta-cells and exosomes
Total RNA from cell or exosome preparations was extracted using the miRNeasy kit (Qiagen) and quantified with a NanoDrop1000 spectrophotometer (Witec AG). The size of the RNAs isolated from MIN6B1 cells or present in exosomes was analyzed using a Bioanalyzer (Agilent Technology).
Quantification of mature miRNA levels
Expression of mature miRNAs was quantified with the miRCURY LNATM Universal RT microRNA PCR kit (Exiqon). Briefly, 200 ng of exosomal or cellular RNAs were used for reverse transcription (RT) in a final volume of 20 μl. Each RT reaction was diluted 10 times in RNase-free water and 8 μl of the cDNA template was combined to the ExiLENT SYBRgreen master mix. qPCR reactions were carried out in triplicates using the CFX Real-Time PCR Detection System (BioRad). miRNA expression in exosomes was normalized to the amount of RNA and expressed as Relative Fluorescence Units (RFU) or compared to control condition whenever possible. The UniSp6 RNA spike-in control (Exiqon) was used as additional internal reference. For this purpose, 0.15 fmol of UniSp6 (corresponding to about 108 copies) was added to the RT reaction and was measured by qPCR using specific primers. miRNA expression in beta-cells was normalized to U6 content.
After isolation, exosomes were collected in 150 μl PBS and 20 ρmol of an oligonucleotide duplex containing the mature miR-142-3p sequence (Eurogentec) were spiked in each sample. Samples were then divided in two aliquots. RNase A (0.5 U) and RNase T1 (15 U) enzymes (Ambion) were added to the first set of tubes while the others were incubated without the enzymes. RNase digestion was performed for 30 min at 37°C. At the end of the incubation, RNA was extracted as described above.
MIN6B1 cells were transiently transfected for 48 h or 72 h using Lipofectamine 2000TM (Invitrogen) according to manufacturer’s instructions with pMSCV-miR146 (or pMSCV-control plasmid) or with oligo-cel-miR-238 (containing the mature sequence of C. elegans miR-238). A pool of 4 siRNAs (SMARTpool from Dharmacon) was used to knockdown Ago2 expression. A custom-designed siRNA duplex directed against green fluorescent protein (siGFP) was used as negative control for siAgo2 and cel-miR-238 experiments. Culture media were changed 8 h after transfection for complete DMEM media, in order to remove transfection reagents and avoid possible contamination of the incubation media with untransfected oligonucleotides.
MIN6B1 cells were incubated for 48 h in full DMEM complemented with exosome-free FCS, in the absence or presence of cytokines. At the end of the incubation, the media were collected for exosome isolation and total RNA was extracted from both exosomes and cells. Global miRNA expression profiling was carried out at the Genomic Technologies Facility of the University of Lausanne using the Agilent Technologies miRNA Gene Microarrays. The microarrays included probes for 650 mouse miRNAs listed on http://www.mirbase.org/ (2010). For each condition, 100 ng of total cellular or exosomal RNA was analyzed. Computational analysis of optical signal-to-noise ratio was performed using the software Feature Extraction (version 10.5.1.1). A miRNA was considered “not detected” if the optical signal was too low or too variable. Quantile normalization with the software Genespring (version GX 11.0.2) was used to normalize all the samples. Comparisons between groups were made using Student t test, with adjusted p-values based on all the 650 miRNAs included in the microarray.
MIN6B1 or dissociated mouse islet cells were incubated for 2 min with 1 μg/ml of Hoechst 33342 (Invitrogen). Cells displaying pycnotic nuclei were scored under fluorescence microscopy (AxioCam MRc5, Zeiss). A minimum of five different fields per experiment for a total of at least thousand cells were counted for each experimental condition.
MIN6B1 cells were seeded on poly-L-lysine-laminin-coated glass coverslips. BrdU (Roche) was added to the incubation medium for the last 6 h of culture. Thereafter, MIN6B1 cells were fixed in cold methanol and permeabilized using PBS supplemented with 0.5% saponin for 15 minutes. The coverslips were incubated in blocking buffer (PBS containing 0.5% saponin and 1% BSA) for 30 min and then sequentially exposed to a mouse anti-BrdU antibody (diluted 1/1400, Cell Signaling) for 1 h and to a goat anti-mouse Alexa Fluor 555 antibody (diluted 1/400, Invitrogen) for another 1 h. Finally, the cell nuclei were stained with Hoechst 33342 (1 μg/ml, Invitrogen) for 1 minute. Coverslips were mounted on microscope glass slides with Fluor-Save mounting medium (VWR International SA) and were visualized with a Zeiss Axiovision fluorescence microscope.
MIN6B1 were pre-incubated at 2 mM glucose for 30 min in Krebs-Ringer bicarbonate buffer containing 25 mM HEPES (KRBH; pH 7.4) and 0.1% BSA. The cells were then incubated for 45 min in KRBH, 0.1% BSA at 2 or 20 mM glucose. At the end of the incubation, the media were collected for insulin measurement and the cells recovered in acidified ethanol (0.2 mM HCl in 75% ethanol) or in lysis buffer for the determination of cellular insulin or protein content, respectively. Insulin levels were measured by ELISA (Mercodia) and proteins by Bradford (BioRad).
Data are expressed as means ± SD. Statistical significances were determined using one-way ANOVA of the means, followed by post-hoc Dunnett’s or Tukey’s test (GraphPad Software, USA). For the microarray analysis, comparisons between groups were made using Student t test, with adjusted p-values based on the Benjamini-Hochberg false discovery rate procedure taking in to account all the 650 miRNAs included in the microarray.
We thank Bryan Gonzalez and Sonia Gattesco for their technical expertise. This work was supported by grants from the Swiss National Science Foundation (310030–146138) and European Foundation for the Study of Diabetes (RR) and from the Fondation pour la Recherche Médicale (DRM20101220456) and from the biopharmaceutical company AstraZeneca (SR). CG is supported by fellowships from the Fonds de la Recherche en Santé du Québec, the Société Francophone du Diabète and the Canadian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
- Dumortier O, Hinault C, Van Obberghen E. MicroRNAs and metabolism crosstalk in energy homeostasis. Cell Metab. 2013;18:312–24.View ArticlePubMedGoogle Scholar
- Eliasson L, Esguerra JL. Role of non-coding RNAs in pancreatic beta-cell development and physiology. Acta Physiol (Oxf). 2014;211:273–84.View ArticleGoogle Scholar
- Guay C, Jacovetti C, Nesca V, Motterle A, Tugay K, Regazzi R. Emerging roles of non-coding RNAs in pancreatic beta-cell function and dysfunction. Diabetes Obes Metab. 2012;14 Suppl 3:12–21.View ArticlePubMedGoogle Scholar
- Kaspi H, Pasvolsky R, Hornstein E. Could microRNAs contribute to the maintenance of beta cell identity? Trends Endocrinol Metab. 2014;25:285–92.View ArticlePubMedGoogle Scholar
- Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–33.View ArticlePubMed CentralPubMedGoogle Scholar
- Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108:5003–8.View ArticlePubMed CentralPubMedGoogle Scholar
- Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol. 2009;11:1143–9.View ArticlePubMedGoogle Scholar
- Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13:423–33.View ArticlePubMed CentralPubMedGoogle Scholar
- Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654–9.View ArticlePubMedGoogle Scholar
- Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9:581–93.View ArticlePubMedGoogle Scholar
- Hurley JH, Odorizzi G. Get on the exosome bus with ALIX. Nat Cell Biol. 2012;14:654–5.View ArticlePubMedGoogle Scholar
- Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319:1244–7.View ArticlePubMedGoogle Scholar
- Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12:19–30. sup pp 11–13.View ArticlePubMedGoogle Scholar
- Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56:1733–41.View ArticlePubMedGoogle Scholar
- Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470–6.View ArticlePubMed CentralPubMedGoogle Scholar
- Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009;19:43–51.View ArticlePubMedGoogle Scholar
- Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem. 2010;285:17442–52.View ArticlePubMed CentralPubMedGoogle Scholar
- Camussi G, Deregibus MC, Bruno S, Grange C, Fonsato V, Tetta C. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res. 2011;1:98–110.PubMed CentralPubMedGoogle Scholar
- Boon RA, Vickers KC. Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol. 2013;33:186–92.View ArticlePubMed CentralPubMedGoogle Scholar
- Fernandez-Messina L, Gutierrez-Vazquez C, Rivas-Garcia E, Sanchez-Madrid F, de la Fuente H. Immunomodulatory role of microRNAs transferred by extracellular vesicles. Biol Cell. 2015;107:61–77.View ArticlePubMedGoogle Scholar
- Figliolini F, Cantaluppi V, De Lena M, Beltramo S, Romagnoli R, Salizzoni M, et al. Isolation, characterization and potential role in beta cell-endothelium cross-talk of extracellular vesicles released from human pancreatic islets. PLoS One. 2014;9:e102521.View ArticlePubMed CentralPubMedGoogle Scholar
- Lee HS, Jeong J, Lee KJ. Characterization of vesicles secreted from insulinoma NIT-1 cells. J Proteome Res. 2009;8:2851–62.View ArticlePubMedGoogle Scholar
- Palmisano G, Jensen SS, Le Bihan MC, Laine J, McGuire JN, Pociot F, et al. Characterization of membrane-shed microvesicles from cytokine-stimulated beta-cells using proteomics strategies. Mol Cell Proteomics. 2012;11:230–43.View ArticlePubMed CentralPubMedGoogle Scholar
- Sheng H, Hassanali S, Nugent C, Wen L, Hamilton-Williams E, Dias P, et al. Insulinoma-released exosomes or microparticles are immunostimulatory and can activate autoreactive T cells spontaneously developed in nonobese diabetic mice. J Immunol. 2011;187:1591–600.View ArticlePubMed CentralPubMedGoogle Scholar
- Zhu Q, Kang J, Miao H, Feng Y, Xiao L, Hu Z, et al. Low-dose cytokine-induced neutral ceramidase secretion from INS-1 cells via exosomes and its anti-apoptotic effect. Febs J. 2014;281:2861–70.View ArticlePubMedGoogle Scholar
- Bravo-Egana V, Rosero S, Molano RD, Pileggi A, Ricordi C, Dominguez-Bendala J, et al. Quantitative differential expression analysis reveals miR-7 as major islet microRNA. Biochem Biophys Res Commun. 2008;366:922–6.View ArticlePubMed CentralPubMedGoogle Scholar
- Roggli E, Britan A, Gattesco S, Lin-Marq N, Abderrahmani A, Meda P, et al. Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes. 2010;59:978–86.View ArticlePubMed CentralPubMedGoogle Scholar
- Roggli E, Gattesco S, Caille D, Briet C, Boitard C, Meda P, et al. Changes in microRNA expression contribute to pancreatic beta-cell dysfunction in prediabetic NOD mice. Diabetes. 2012;61:1742–51.View ArticlePubMed CentralPubMedGoogle Scholar
- Goldberger N, Walker RC, Kim CH, Winter S, Hunter KW. Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b. Cancer Res. 2013;73:2671–81.View ArticlePubMed CentralPubMedGoogle Scholar
- Lovis P, Roggli E, Laybutt DR, Gattesco S, Yang JY, Widmann C, et al. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes. 2008;57:2728–36.View ArticlePubMed CentralPubMedGoogle Scholar
- Christensen LL, Tobiasen H, Holm A, Schepeler T, Ostenfeld MS, Thorsen K, et al. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer. Int J Cancer. 2013;133:67–78.View ArticlePubMedGoogle Scholar
- Park H, Huang X, Lu C, Cairo MS, Zhou X. MicroRNA-146a and MicroRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting traf6 and irak1 proteins. J Biol Chem. 2015;290:2831–41.View ArticlePubMedGoogle Scholar
- Zhou Y, Jiang H, Gu J, Tang Y, Shen N, Jin Y. MicroRNA-195 targets ADP-ribosylation factor-like protein 2 to induce apoptosis in human embryonic stem cell-derived neural progenitor cells. Cell Death Dis. 2013;4:e695.View ArticlePubMed CentralPubMedGoogle Scholar
- Creevey L, Ryan J, Harvey H, Bray IM, Meehan M, Khan AR, et al. MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1. Mol Cancer. 2013;12:23.View ArticlePubMed CentralPubMedGoogle Scholar
- Jain R, Lammert E. Cell-cell interactions in the endocrine pancreas. Diabetes Obes Metab. 2009;11 Suppl 4:159–67.View ArticlePubMedGoogle Scholar
- Rutter GA, Hodson DJ. Beta cell connectivity in pancreatic islets: a type 2 diabetes target? Cell Mol Life Sci. 2015;72:453–67.View ArticlePubMedGoogle Scholar
- Nolte-’t Hoen EN, Buermans HP, Waasdorp M, Stoorvogel W, Wauben MH, t Hoen PA. Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res. 2012;40:9272–85.View ArticlePubMed CentralPubMedGoogle Scholar
- Forterre A, Jalabert A, Chikh K, Pesenti S, Euthine V, Granjon A, et al. Myotube-derived exosomal miRNAs downregulate Sirtuin1 in myoblasts during muscle cell differentiation. Cell Cycle. 2014;13:78–89.View ArticlePubMed CentralPubMedGoogle Scholar
- Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, Perez-Hernandez D, Vazquez J, Martin-Cofreces N, et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013;4:2980.View ArticlePubMed CentralPubMedGoogle Scholar
- Squadrito ML, Baer C, Burdet F, Maderna C, Gilfillan GD, Lyle R, et al. Endogenous RNAs modulate MicroRNA sorting to exosomes and transfer to acceptor cells. Cell Rep. 2014;8:1432–46.View ArticlePubMedGoogle Scholar
- Eizirik DL, Mandrup-Poulsen T. A choice of death–the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia. 2001;44:2115–33.View ArticlePubMedGoogle Scholar
- Maedler K, Schumann DM, Sauter N, Ellingsgaard H, Bosco D, Baertschiger R, et al. Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets. Diabetes. 2006;55:2713–22.View ArticlePubMedGoogle Scholar
- Bonner C, Bacon S, Concannon CG, Rizvi SR, Baquie M, Farrelly AM, et al. INS-1 cells undergoing caspase-dependent apoptosis enhance the regenerative capacity of neighboring cells. Diabetes. 2010;59:2799–808.View ArticlePubMed CentralPubMedGoogle Scholar
- Lilla V, Webb G, Rickenbach K, Maturana A, Steiner DF, Halban PA, et al. Differential gene expression in well-regulated and dysregulated pancreatic beta-cell (MIN6) sublines. Endocrinol. 2003;144:1368–79.View ArticleGoogle Scholar
- Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M, Newgard CB. Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes. 2000;49:424–30.View ArticlePubMedGoogle Scholar
- Gotoh M, Maki T, Satomi S, Porter J, Bonner-Weir S, O’Hara CJ, et al. Reproducible high yield of rat islets by stationary in vitro digestion following pancreatic ductal or portal venous collagenase injection. Transplant. 1987;43:725–30.View ArticleGoogle Scholar
- Lasser C, Eldh M, Lotvall J. Isolation and characterization of RNA-containing exosomes. J Vis Exp. 2012;59:e3037.PubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.